Cytosorbents Crp Company Leadership
| CTSO Stock | USD 0.93 0.01 1.09% |
Cytosorbents Crp employs about 186 people. The company is managed by 11 executives with a total tenure of roughly 434 years, averaging almost 39.0 years of service per executive, having 16.91 employees per reported executive. Analysis of Cytosorbents Crp's management performance can provide insight into the firm performance.
Cytosorbents |
Cytosorbents Crp Management Team Effectiveness
The company has return on total asset (ROA) of (0.2793) % which means that it has lost $0.2793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.185) %, meaning that it created substantial loss on money invested by shareholders. Cytosorbents Crp's management efficiency ratios could be used to measure how well Cytosorbents Crp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.61. In addition to that, Return On Capital Employed is likely to grow to -0.77. At this time, Cytosorbents Crp's Total Assets are very stable compared to the past year. As of the 26th of November 2024, Non Current Assets Total is likely to grow to about 28.9 M, while Total Current Assets are likely to drop about 17.6 M.As of the 26th of November 2024, Common Stock Shares Outstanding is likely to grow to about 46.9 M, though Net Loss is likely to grow to (28.1 M).
Cytosorbents Crp Workforce Comparison
Cytosorbents Crp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 10,242. Cytosorbents Crp claims roughly 186 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.49) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.46. Cytosorbents Crp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cytosorbents Crp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cytosorbents Crp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cytosorbents Crp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cytosorbents Crp Notable Stakeholders
A Cytosorbents Crp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cytosorbents Crp often face trade-offs trying to please all of them. Cytosorbents Crp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cytosorbents Crp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vincent MS | President COO | Profile | |
| CPA CPA | CFO Sec | Profile | |
| Robert MD | CoChairman Consultant | Profile | |
| MS MS | Pres COO | Profile | |
| Christian MD | Executive Marketing | Profile | |
| MS MBA | Senior Development | Profile | |
| Terri MBA | Vice Communications | Profile | |
| FACC FESC | Chief Officer | Profile | |
| Irina Kulinets | Senior Affairs | Profile | |
| Peter CPA | Chief Officer | Profile | |
| Jodi Hoover | Executive | Profile |
About Cytosorbents Crp Management Performance
The success or failure of an entity such as Cytosorbents Crp often depends on how effective the management is. Cytosorbents Crp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cytosorbents management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cytosorbents management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.58) | (0.61) | |
| Return On Capital Employed | (0.81) | (0.77) | |
| Return On Assets | (0.54) | (0.56) | |
| Return On Equity | (1.22) | (1.16) |
Cytosorbents Crp Workforce Analysis
Traditionally, organizations such as Cytosorbents Crp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cytosorbents Crp within its industry.Cytosorbents Crp Manpower Efficiency
Return on Cytosorbents Crp Manpower
| Revenue Per Employee | 195.4K | |
| Revenue Per Executive | 3.3M | |
| Net Loss Per Employee | 153.3K | |
| Net Loss Per Executive | 2.6M | |
| Working Capital Per Employee | 60K | |
| Working Capital Per Executive | 1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share 0.72 | Quarterly Revenue Growth 0.066 | Return On Assets (0.28) | Return On Equity (1.19) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.